Covered recipient · General Payments record
JAMIE YI
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2023–2024
$894.62
- Reported across 24 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $553.61 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $412.00 | 14 |
| Galderma Laboratories, L.P. | $141.61 | 5 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $114.93 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108449475 | CMS |
| ABBVIE INC. | $53.84 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108449477 | CMS |
| ABBVIE INC. | $42.30 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108449479 | CMS |
| ABBVIE INC. | $18.72 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108449481 | CMS |
| ABBVIE INC. | $26.48 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108449483 | CMS |
| ABBVIE INC. | $9.70 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108449485 | CMS |
| ABBVIE INC. | $21.37 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108449487 | CMS |
| ABBVIE INC. | $24.71 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108449489 | CMS |
| ABBVIE INC. | $20.45 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108449491 | CMS |
| ABBVIE INC. | $10.91 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108449493 | CMS |
| ABBVIE INC. | $19.35 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108449495 | CMS |
| ABBVIE INC. | $1.22 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108449497 | CMS |
| ABBVIE INC. | $20.21 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108449499 | CMS |
| ABBVIE INC. | $27.81 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108449501 | CMS |
| Galderma Laboratories, L.P. | $99.06 | 06/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145402247 | CMS |
| Galderma Laboratories, L.P. | $8.21 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145402249 | CMS |
| Galderma Laboratories, L.P. | $13.49 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145402251 | CMS |
| Galderma Laboratories, L.P. | $9.16 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145402253 | CMS |
| Galderma Laboratories, L.P. | $11.69 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145402255 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.